Medtronic initiates clinical study to assess safety of drug-eluting stents
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UAB will take part in global clinical trial for COVID-19 treatment
UAB will take part in a National Institutes of Health (NIH)-sponsored global clinical trial to evaluate the safety and efficacy of therapeutic agents in hospitalized adult patients who have been diagnosed with COVID-19 (coronavirus). The drug remd.....»»
Acceleron Pharma stock soars more than 50% on hypertension drug study
Acceleron Pharma Inc. shares surged in the extended session late Monday after the biotech drug maker said its hypertension drug hit key goals in a mid-stage clinical trial. Acceleron shares soared 56%.....»»
Merck stock slides as lung-cancer drug misses a study endpoint
Merck & Co. shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0......»»
Mesoblast Submits Clinical Efficacy and Safety Data to FDA in Rolling Biologics License Application for Remestemcel-l
Mesoblast Limited (Nasdaq: MESO) announced that the United States Food and Drug Administration (US FDA) has confirmed receipt of Mesoblast's .....»»
vTv Therapeutics to complete Phase 2 of Alzheimer’s study by 2021
vTv Therapeutics (NSDQ:VTVT), the High Point biopharmaceutical company, expects to complete Phase 2 of its Alzheimer’s disease study by 2021. The clinical trial for azeliragon, a drug created by the company to slow or halt the progression of t.....»»
Fate Therapeutics" stock rises on early-stage cancer drug data
Shares of Fate Therapeutics gained 37% after it shared promising data from one clinical and one preclinical study for its experimental cancer immunotherapy treatments. The company is testing two therapies, FT516 and FT500, in.....»»
CymaBay Halts Study On Lead Clinical Program, Stock Crashes
CymaBay Therapeutics Inc (NASDAQ: CBAY) shares are losing more than 75% of their value Monday after the company said it's halting the development of its lead drug, seladelpar. 0 read more.....»»
NeuroVive Pharmaceutical AB Interim Report January - September 2019
STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important events July - September NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study NeuroSTAT r.....»»
Turning Point Therapeutics initiates Phase 1/2 clinical study of repotrectinib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Turning Point Therapeutics initiates Phase 1/2 clinical study of TPX-0046
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Merck KGaA and Pfizer said Friday that a late-stage clinical trial testing Bavencio as a first-line maintenance treatment for patients with certain forms of gastric cancer failed to meet the study's primary endpoints for survival. The cur.....»»
Tilray Backs First Human Study On Medical Marijuana Used For Breast Cancer Drug Side Effects
Tilray, Inc. (NASDAQ: TLRY) announced Thursday it has imported medical cannabis into the U.S. from Canada to back a new clinical trial. read more.....»»
Zosano Pharma initiates Phase 2/3 clinical study in cluster headache
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Nektar initiates Phase 1 clinical study of NKTR-255 candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Medtronic initiates worldwide study of EV ICD system for fast heart rhythms
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cassava Sciences initiates Phase 2b clinical study of PTI-125 in Alzheimer"s
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Acadia Stops Nuplazid Study Early After Drug Shows "Statistically Superior Efficacy" In Dementia-Related Psychosis
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares are soaring to their highest level in about two years following a clinical trial readout from the company. read more.....»»
Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress
- Positive early safety and efficacy data with nomacopan Phase II clinical study in patients with mild-to-moderate bullous pemph.....»»
AstraZeneca"s Drug Combo To Treat Non-Small Cell Lung Cancer Stumbles In Late-Stage Study
AstraZeneca plc (NYSE: AZN) faced a clinical setback in a study evaluating a combo drug regimen in non-small cell lung cancer, or NSCLC. read more.....»»
PAVmed completes clinical safety study procedures for CarpX 510 resubmission
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»